Johns Hopkins registers Phase 2 HEROIC caregiver trial in advanced heart failure
A new NCT record describes a multi-site trial testing a nurse-led palliative care intervention for heart failure caregivers and patients, not yet recruiting.
Johns Hopkins University registered one new trial this week related to heart failure caregiving.
- HEROIC program, Phase 2, advanced heart failure and caregivers: the study will test the mechanisms of a multi-component, nurse-led, primary palliative care intervention called HEROIC intended to improve caregiver mental well-being, patient health-related quality of life, and unplanned acute care in advanced heart failure.1 The trial is sponsored by Johns Hopkins University with the National Heart, Lung, and Blood Institute as collaborator, is listed as not yet recruiting, and plans a multi-site, randomized controlled trial with a target enrollment of 500 people with heart failure and their caregivers.1
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.